Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Appointed director
|
|
APPLIED GENETIC TECHNOLOGIES CORP (AGTC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/24/2018 |
8-K
| Appointed a new director|
Docs:
|
"AGTC Appoints William Aliski to its Board of Directors GAINESVILLE, Fla., and CAMBRIDGE, Mass., September 24, 2018 - Applied Genetic Technologies Corporation , a biotechnology company conducting human clinical trials of adeno-associated virus -based gene therapies for the treatment of rare diseases, today announced it has appointed William Aliski to the company's Board of Directors. “Bill will be an invaluable addition to the AGTC Board of Directors and leadership team,” said Sue Washer, President and CEO of AGTC. “His deep knowledge of biotechnology and the rare disease space, coupled with his consistent record of providing strategic counsel to clinical-stage companies, will be beneficial to AGTC as we continue to advance our lead candidates through clinical trials.” Mr. Aliski has extens..." |
|
| 08/18/2016 |
8-K
| Form 8-K - Current report |
| 03/20/2015 |
8-K
| Form 8-K - Current report |
|
|